Leslie V. Norwalk
Director at Neurocrine Biosciences · 13 reported transactions in 4 companies · latest trade Jul 28, 2026
Their trades
Sold | Jul 28, 2026 | Jul 28, 2026 close $182.83 → Oct 29, 2026 close $146.38. S&P 500 +3.9% over the same days. | ||
Sold | Jun 4, 2026 | Jun 4, 2026 close $167.35 → Oct 29, 2026 close $146.38. S&P 500 +1.6% over the same days. | ||
Sold | Jan 8, 2026 | Jan 8, 2026 close $94.62 → Oct 28, 2026 close $81.26. S&P 500 +12.0% over the same days. | ||
Sold | Dec 16, 2025 | Dec 16, 2025 close $148.74 → Oct 29, 2026 close $146.38. S&P 500 +13.3% over the same days. | ||
Sold | Dec 15, 2025 | Dec 15, 2025 close $154.06 → Oct 29, 2026 close $146.38. S&P 500 +13.0% over the same days. |
$227.5K
Jul 28, 2026 close $182.83 → Oct 29, 2026 close $146.38. S&P 500 +3.9% over the same days.
$210.1K
Jun 4, 2026 close $167.35 → Oct 29, 2026 close $146.38. S&P 500 +1.6% over the same days.
SoldGlobus Medical
$202.2K
Jan 8, 2026 close $94.62 → Oct 28, 2026 close $81.26. S&P 500 +12.0% over the same days.
$184.6K
Dec 16, 2025 close $148.74 → Oct 29, 2026 close $146.38. S&P 500 +13.3% over the same days.
$761.1K
Dec 15, 2025 close $154.06 → Oct 29, 2026 close $146.38. S&P 500 +13.0% over the same days.